Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02703220 · ClinicalTrials.gov registry record · Phase 4
Sleep Apnea in Elderly
A Phase 4 study of Sleep Apnea and Elderly Adults, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02703220 is a Phase 4 study of Sleep Apnea and Elderly Adults that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 100 participants, below the 2,986-participant average among 36 other Sleep Apnea trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02703220, a Phase 4 study of Sleep Apnea and Elderly Adults, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Sleep-disordered breathing (SDB or sleep apnea) is very common among elderly Veterans and leads to increased morbidity and mortality in this population. The proposal aims to identity whether oxygen, finasteride and acetazolamide can be effective in reducing unstable breathing and eliminating sleep apnea in the elderly via different mechanisms. This proposal will enhance the investigators' understanding of the pathways that contribute to the development of sleep apnea in the elderly. The investigators expect that the results obtained from this study will positively impact the health of Veterans by identifying new treatment modalities for sleep apnea. A cumulative effect of the investigators' research will fulfill the long-term goal of improving the quality of life of elderly Veterans suffering from sleep apnea and its potential life-threatening complications.
Conditions Studied
Interventions
- DRUG Acetazolamide
- DRUG Finasteride
- OTHER Hyperoxia/oxygen
Study Locations (1)
Michigan
- John D. Dingell VA Medical Center, Detroit, MI - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-07-03 |
| Est. Completion | 2026-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02703220
The ClinicalTrials.gov registry entry for NCT02703220 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,986-participant average among 36 other Sleep Apnea trials with a reported enrollment target (97% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sleep Apnea appearing as the primary indexed condition, and to 3 interventions - of which Acetazolamide is the first listed.
NCT02703220 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT02703220 about?
NCT02703220 is a clinical study titled "Sleep Apnea in Elderly". Sleep-disordered breathing (SDB or sleep apnea) is very common among elderly Veterans and leads to increased morbidity and mortality in this population. The proposal aims to identity whether oxygen, finasteride and acetazolamide can be effective in reducing unstable breathing and eliminating sleep a...
What is the current status of trial NCT02703220?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2015-07-03. Estimated completion is 2026-07-31.
What conditions does trial NCT02703220 study?
This clinical trial studies the following conditions: Sleep Apnea, Elderly Adults.
What interventions are being tested in trial NCT02703220?
The interventions under investigation include: Acetazolamide (DRUG), Finasteride (DRUG), Hyperoxia/oxygen (OTHER).
Who is sponsoring clinical trial NCT02703220?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02703220 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study
RECRUITING · Phase 4
-
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
RECRUITING · Phase 4
-
Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury
RECRUITING · Phase 4
-
Research Framework Exploring Sleep Health
RECRUITING
-
Mechanisms of Prediabetic States in Sleep Apnea
RECRUITING · NA
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.